• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 522319 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414083456 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414083456 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Watch for Continued Losses in Shares of Aastrom Biosciences (ASTM)

Published on Mon, 06/24/2013 - 14:23
By Peter Chu

Shares of Aastrom Biosciences (NASDAQ:ASTM) traded at a new 52-week low today of $0.45. Approximately 59,000 shares have changed hands today, as compared to an average 30-day volume of 171,000 shares.

Potential upside of 155.3% exists for Aastrom Biosciences, based on a current level of $0.48 and analysts' average consensus price target of $1.23. The stock should run into initial resistance at its 50-day moving average (MA) of $0.59 and subsequent resistance at its 200-day MA of $1.16.

In the past 52 weeks, shares of Aastrom Biosciences have traded between the current low of $0.45 and a high of $2.20 and are now at $0.48. In the last five trading sessions, the 50-day moving average (MA) has fallen 3.7% while the 200-day MA has slid 2.4%.

Aastrom Biosciences, Inc. develops autologous stem/progenitor cell products for the repair/regeneration of tissues based on Tissue Repair Cell (TRC) adult stem cell technology. The Company's products contain bone marrow stem and progenitor cells that are produced from cells originating from the patient.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Hot Stock: Sonus Networks, Shares Gain 8...

Sonus Networks (NASDAQ:SONS) is one of today's best performing low-priced stocks, up 8. ...

Shares of Papa John's International Unde...

One of today's stocks on the move is Papa John's International (NASDAQ:PZZA), down 2.1% ...

Virtusa Shares Climbing Higher, Up 2.1%...

Virtusa (NASDAQ:VRTU) is one of today's biggest movers, up 2.1% to $36.05. The S&P is ...

Cognex Makes a Move: Up 2.1%...

One of today's stocks on the move is Cognex (NASDAQ:CGNX), up 2.1% to $38.89. The Dow ...

Stock Investors Bid Up Shares of Mercury...

Mercury Computer Systems (NASDAQ:MRCY) is a company whose shares are active, trading 2. ...

Shares of Time Warner Cable Receive a Bo...

One of today's notable stocks on the rise is Time Warner Cable (NYSE:TWC), up 2.1% to $ ...

Hologic Shares Climbing Higher, Up 2.1%...

One of today's stocks on the move is Hologic (NASDAQ:HOLX), up 2.1% to $24.83. The Dow ...

Heartland Payment Systems Shares Climbin...

Heartland Payment Systems (NYSE:HPY), a company whose shares are moving quickly, is tra ...